Markel CapEx decreased by 25.1% to $47.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $40.71M to $47.27M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 9.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.09M | $25.02M | $64.49M | $51.70M | $58.85M | $98.74M | $45.43M | $37.18M | $42.26M | $75.65M | $103.53M | $71.95M | $57.20M | $51.89M | $73.95M | $40.71M | $50.64M | $52.42M | $63.12M | $47.27M |
| QoQ Change | — | -0.3% | +157.8% | -19.8% | +13.8% | +67.8% | -54.0% | -18.2% | +13.7% | +79.0% | +36.9% | -30.5% | -20.5% | -9.3% | +42.5% | -44.9% | +24.4% | +3.5% | +20.4% | -25.1% |
| YoY Change | — | — | — | — | +134.6% | +294.6% | -29.6% | -28.1% | -28.2% | -23.4% | +127.9% | +93.5% | +35.3% | -31.4% | -28.6% | -43.4% | -11.5% | +1.0% | -14.6% | +16.1% |